Chuanxian Particles Treatment VD Of Blood-stasis Obstruction Syndrome Clinical Observation

Purpose: This topic using blood circulation removing extravasted blood, invigorates thekidney the longan law, anti-winds the card to the vascular stupid-ecchymosis the patient tocarry on the clinical curative effect observation, through statistics analysis, appraises theSichuan immortal pellet treatment vascular stupid validity, and will develop the new medicinefor the future clinical research to provide the foundation.Method: According to the diagnostic criteria of the International Association forvascular dementia, patients met the inclusion criteria, according to doctor ordered paihao(1-48) group, were divided into two groups:24cases control group:24cases. Treatmentgroup given chuanxian particle,30g/bags,3oral.Chuanxian Particle simulation control groupgiven doses,30g/bags,3oral. Duration:24weeks for the entire course of treatment.Observation of therapeutic effect of two groups of subjects are there differences statisticallysignificant. Evaluation of clinical effects.Result: The clinical research, through cognitive function assessment MMSE curativeeffect analysis, two groups of patients were compared, the treatment group24cases, patientswith significant efficiency29.17%, total effective rate was79.17%. Control group24cases,show the efficiency of4.17%, total effective rate20.33%, the results showed that the curativeeffect of treatment group was obviously better than the control group; TCM symptomscurative effect, according to the results of the treatment group24cases, patients withsignificant efficiency29.17%, total effective rate83.33%, control group24cases, show theefficiency of8.33%, total effective rate29.17%, comparing the two groups have significantdifference (P <0.05). TCM symptoms curative effect comparison, the treatment group wasbetter than the control group.Conclusion:Clinical studies have shown that Chuanxian particle for vascular dementiasyndrome of blood stasis blocking collaterals efficacy, the curative effect is significantlybetter than the control group, toxic side effects and adverse reactions, has better clinicalapplication value.